Acurx Pharmaceuticals Yönetim
Yönetim kriter kontrolleri 1/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Dave Luci
İcra Kurulu Başkanı
US$1.0m
Toplam tazminat
| CEO maaş yüzdesi | 46.4% |
| CEO görev süresi | 6.8yrs |
| CEO sahipliği | 6.8% |
| Yönetim ortalama görev süresi | Veri yok |
| Yönetim Kurulu ortalama görev süresi | 3.3yrs |
Son yönetim güncellemeleri
Recent updates
Acurx Pharmaceuticals (NASDAQ:ACXP) Will Have To Spend Its Cash Wisely
Aug 11
Acurx Sell-Off Presents Opportunity Before Upcoming Data Release
Jan 22Here's Why We're Not Too Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation
Oct 30Is Acurx Pharmaceuticals (NASDAQ:ACXP) In A Good Position To Invest In Growth?
Jul 15Is Acurx Pharmaceuticals (NASDAQ:ACXP) In A Good Position To Deliver On Growth Plans?
Mar 04Here's Why We're Watching Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation
Nov 16Acurx, Pharmaceuticals drops 8.8%, announces $4.25M direct offering
Jul 25Here's Why We're Watching Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation
May 13Here's Why We're Not Too Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation
Jan 22Companies Like Acurx Pharmaceuticals (NASDAQ:ACXP) Can Afford To Invest In Growth
Sep 30New Antibiotics Needed For Drug-Resistant Infections, Acurx Pharmaceuticals May Have The Answers
Aug 27CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$16m |
| Jun 30 2024 | n/a | n/a | -US$17m |
| Mar 31 2024 | n/a | n/a | -US$16m |
| Dec 31 2023 | US$1m | US$475k | -US$15m |
| Sep 30 2023 | n/a | n/a | -US$13m |
| Jun 30 2023 | n/a | n/a | -US$13m |
| Mar 31 2023 | n/a | n/a | -US$12m |
| Dec 31 2022 | US$655k | US$475k | -US$12m |
| Sep 30 2022 | n/a | n/a | -US$11m |
| Jun 30 2022 | n/a | n/a | -US$13m |
| Mar 31 2022 | n/a | n/a | -US$14m |
| Dec 31 2021 | US$4m | US$364k | -US$13m |
| Sep 30 2021 | n/a | n/a | -US$11m |
| Jun 30 2021 | n/a | n/a | -US$8m |
| Mar 31 2021 | n/a | n/a | -US$5m |
| Dec 31 2020 | US$596k | US$277k | -US$5m |
| Dec 31 2019 | US$290k | US$267k | -US$6m |
Tazminat ve Piyasa: Dave 'nin toplam tazminatı ($USD 1.02M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 647.72K ).
Tazminat ve Kazançlar: Dave şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Dave Luci (57 yo)
6.8yrs
Görev süresi
US$1,023,878
Tazminat
Mr. David P. Luci, also known as Dave, CPA, J.D. Esq. served as Chairman of the Board at AMERI Holdings, Inc. since August 16, 2018 until December 12, 2018.Mr. Luci is the Co-Founder of Acurx Pharmaceutic...
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 6.8yrs | US$1.06m | 5.94% $ 1.1m | |
| Co-Founder | 6.8yrs | US$1.02m | 6.76% $ 1.3m | |
| Independent Director | 3.3yrs | US$78.94k | 0.019% $ 3.6k | |
| Independent Director | 3.3yrs | US$73.94k | 0.0095% $ 1.8k | |
| Independent Director | 3.3yrs | US$76.44k | 0.077% $ 14.8k | |
| Independent Director | 6.1yrs | US$66.44k | 0.72% $ 139.4k | |
| Independent Director & Scientific Advisor | 3.3yrs | US$61.44k | 0.11% $ 21.0k | |
| Scientific Advisor | no data | Veri yok | Veri yok | |
| Scientific Advisor | no data | Veri yok | Veri yok | |
| Scientific Advisor | no data | Veri yok | Veri yok | |
| Scientific Advisor | no data | Veri yok | Veri yok | |
| Scientific Advisor | no data | Veri yok | Veri yok |
3.3yrs
Ortalama Görev Süresi
71yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: ACXP 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.3 yıldır).